Welcome to Pink Sheet
Create an account to read this article
Already a subscriber?
FDA tightens security at Parklawn Building, details bomb threat response procedures.
FDA BOMB THREAT RESPONSE GUIDELINES, PREVIEW OF SECURITY ENHANCEMENTS at the agency's Parklawn Building in Rockville, Md. were issued in a memo dated Aug. 7. FDA is tightening security at the building in the wake of two recent bomb scares telephoned in to Parklawn employees that caused the building to be evacuated and searched. The heightened security measures also bring Parklawn "into compliance with the Department of Justice guidelines mandated by President Clinton." Security consultant reviews of FDA's outbuildings "will begin soon."
More from Archive
More from Pink Sheet
• By
George Tidmarsh has extensive experience in the biopharmaceutical industry and led several drugs to FDA approval.
• By
Innovator drug advocates argued that the number of patents asserted by industry is not too dissimilar to other fields. But should drugs be compared to golf balls?
• By
Testimony during a July 21 ‘expert panel’ could help justify stronger warnings across the class about potential adverse effects on mother and baby. Panelists ranged from clinicians who said depression during pregnancy should be treated, to those who said sadness has been “medicalized."